Francis Witz

3.5k total citations
54 papers, 2.0k citations indexed

About

Francis Witz is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Francis Witz has authored 54 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 24 papers in Public Health, Environmental and Occupational Health and 14 papers in Genetics. Recurrent topics in Francis Witz's work include Acute Lymphoblastic Leukemia research (24 papers), Acute Myeloid Leukemia Research (22 papers) and Chronic Myeloid Leukemia Treatments (14 papers). Francis Witz is often cited by papers focused on Acute Lymphoblastic Leukemia research (24 papers), Acute Myeloid Leukemia Research (22 papers) and Chronic Myeloid Leukemia Treatments (14 papers). Francis Witz collaborates with scholars based in France, Switzerland and Canada. Francis Witz's co-authors include Pierre Bordigoni, Norbert Ifrah, Alain Le Faou, Véronique Venard, Anne‐Sophie Carret, Bruno Lioure, Nöel Milpied, Xavier Thomas, Arnaud Pigneux and Hervé Dombret and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Francis Witz

54 papers receiving 2.0k citations

Peers

Countries citing papers authored by Francis Witz

Since Specialization

Citations

This map shows the geographic impact of Francis Witz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis Witz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis Witz more than expected).

Fields of papers citing papers by Francis Witz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francis Witz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis Witz. The network helps show where Francis Witz may publish in the future.

Co-authorship network of co-authors of Francis Witz

This figure shows the co-authorship network connecting the top 25 collaborators of Francis Witz. A scholar is included among the top collaborators of Francis Witz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francis Witz. Francis Witz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Addition of Lomustine to Idarubicin and Cytarabine Improves the Outcome of Elderly Patients With De Novo Acute Myeloid Leukemia: A Report From the GOELAMS 2010 ·Journal of Clinical Oncology ·Arnaud Pigneux, Jean‐Luc Harousseau, Francis Witz, (unknown), Marie C. Béné, Isabelle Luquet, Mathilde Hunault, Christian Récher, Bruno Lioure, Chantal Himberlin, Martine Escoffre‐Barbe, Christian Berthou, Séverine Lissandre, Nathalie Fegueux, Jean‐Yves Cahn, Éric Jourdan, François Dreyfus, Josy Reiffers, Nöel Milpied, Norbert Ifrah	26
2	Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission 2010 ·Blood ·Norbert-Claude Gorin, Myriam Labopin, Josy Reiffers, Nöel Milpied, Didier Blaise, Francis Witz, Théo de Witte, Giovanna Meloni, Michel Attal, Teresa Bernal, Vanderson Rocha, (unknown)	41
3	Prognostic Value of the ‘Monosomal Karyotype’ Entity in Elderly Patients with AML: a GOELAMS Study of 186 Patients with Unfavourable Cytogenetic Abnormalities. 2009 ·Blood ·Aurore Perrot, Isabelle Luquet, Arnaud Pigneux, Francine Mugneret, Jacques Delaunay, Jean‐Luc Harousseau, Francis Witz, Carole Barin, Jean‐Yves Cahn, Philippe Guardiola, Chantal Himberlin, Christian Récher, Norbert Vey, Bruno Lioure, Olivier Tournilhac, Nathalie Fegueux, Christian Berthou, Martine Escoffre‐Barbe, Marie C. Béné, Norbert Ifrah	3
4	Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS study 2008 ·Leukemia ·Francis Lacombe, Christine Arnoulet, Marc Maynadié, Éric Lippert, Isabelle Luquet, Arnaud Pigneux, Norbert Vey, Olivier Casasnovas, Francis Witz, Marie C. Béné	51
5	Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients 2007 ·Blood ·Jérôme Tamburini, Caroline Elie, Valérie Bardet, Nicolas Chapuis, Sophie Park, Philippe Broët, Pascale Cornillet‐Lefèbvre, Bruno Lioure, Valérie Ugo, Odile Blanchet, Norbert Ifrah, Francis Witz, François Dreyfus, Patrick Mayeux, Catherine Lacombe, Didier Bouscary	112
6	Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome–positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study 2006 ·Blood ·Adrienne de Labarthe, Philippe Rousselot, (unknown), Éric Delabesse, Francis Witz, Sébastien Maury, Delphine Réa, Jean‐Michel Cayuela, (unknown), Oumédaly Reman, Agnès Buzyn, Arnaud Pigneux, Martine Escoffre, Yves Chalandon, Elizabeth Macintyre, Véronique Lhéritier, Jean‐Paul Vernant, Xavier Thomas, Norbert Ifrah, Hervé Dombret	234
7	Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials 2005 ·Leukemia ·Nathalie Dhédin, Hervé Dombret, Xavier Thomas, Véronique Lhéritier, J.-M. Boiron, Françoise Rigal‐Huguet, Norbert Vey, Mathieu Kuentz, Oumédaly Reman, Francis Witz, André Delannoy, Tibor Kovacsovics, Kenneth F. Bradstock, C Charrin, Claude Boucheix, J Gäbert, Didier Blaise, D Fière, J P Vernant	28
8	Intensive Therapy before or during the Conditioning Regimen of Allogeneic Marrow Transplantation in Adult Acute Lymphoblastic Leukemia Patients: We Must Choose to Reduce Toxicity—A Groupe Ouest-Est d’Etude des Leucémies et Autres Maladies du Sang Study 2005 ·Biology of Blood and Marrow Transplantation ·Éric Deconinck, Mathilde Hunault, Nöel Milpied, Marc Bernard, Marc Renaud, B Desablens, Martine Delain, Francis Witz, Bruno Lioure, B. Pignon, Denis Guyotat, Christian Berthou, Jean‐Pierre Jouet, P. Casassus, Norbert Ifrah, Jean‐Michel Boiron	4
9	Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome 2004 ·Bone Marrow Transplantation ·Stéphane Depil, Éric Deconinck, Nöel Milpied, Laurent Sutton, Francis Witz, J. P. Jouet, Gandhi Damaj, Ibrahim Yakoub‐Agha, (unknown)	37
10	Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+ cells 2003 ·Transfusion ·Pierre Feugier, Danièle Bensoussan, (unknown), François Alla, (unknown), Véronique Latger‐Cannard, Cyrille Hulin, Francis Witz, Brigitte Witz, Anne Sophie Carret, Pierre Bordigoni, P Lederlin, C. Janot	32
11	Shwachman–Diamond syndrome with late‐onset neutropenia and fatal acute myeloid leukaemia without maturation: a case report 2003 ·European Journal Of Haematology ·Jean‐François Lesesve, (unknown), (unknown), Francis Witz, Yigal Dror	11
12	Prior treatment with alpha interferon does not adversely  affect the outcome of allogeneic transplantation  for chronic myeloid leukaemia 2002 ·British Journal of Haematology ·Arnaud Pigneux, M-L. Tanguy, Mauricette Michallet, J P Jouet, Mathieu Kuentz, Vernant Jp, Nöel Milpied, Norbert Ifrah, J Cahn, N Gratecos, Oumédaly Reman, H. Curé, Denis Caillot, Francis Witz, (unknown), P Tron, Josy Reiffers, (unknown)	15
13	Treatment of Adenovirus Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation 2001 ·Clinical Infectious Diseases ·Pierre Bordigoni, Anne‐Sophie Carret, Véronique Venard, Francis Witz, Alain Le Faou	200
14	Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM) 1997 ·British Journal of Haematology ·Gèrard Socié, J Cahn, (unknown), Vernant Jp, J. P. Jouet, Norbert Ifrah, Nöel Milpied, Mauricette Michallet, Bruno Lioure, J. L. Pico, Francis Witz, Lysiane Molina, Alain Fischer, V J Bardou, Éliane Gluckman, Josy Reiffers	96
15	Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis 1997 ·Bone Marrow Transplantation ·Olle Ringdén, Myriam Labopin, Éliane Gluckman, JM Hows, B Bradley, HJ Kolb, L Fouillard, N Jacobsen, Vernant Jp, Francis Witz, Harousseau Jl, Gorin Nc	36
16	Agranulocytoses aiguës médicamenteuses. Étude clinique à propos de 30 patients et évolution des étiologies sur 2 décennies 1995 ·La Revue de Médecine Interne ·(unknown), (unknown), Véronique Dorvaux, Francis Witz, (unknown), P Lederlin	18
17	Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapy 1990 ·Cancer ·Nöel Milpied, Christian Gisselbrecht, Jean‐Luc Harousseau, Catherine Sebban, Francis Witz, Xavier Troussard, N Gratecos, Mauricette Michallet, Véronique Leblond, (unknown), D Fière	15
18	Intérêt des hautes doses de cytosine-arabinoside dans le traitement des leucémies aiguës résistantes. 1987 ·La Presse Médicale ·Francis Witz, D Olive, P Lederlin, Pierre Bordigoni, Xavier Troussard, B. Grosbois, G Schaison, Guy Cornu	1
19	[High-dose Cytosine-arabinoside for the Treatment of Resistant Acute-leukemia] 1987 ·La Presse Médicale ·Francis Witz, D Olive, P Lederlin, Pierre Bordigoni, Xavier Troussard, B. Grosbois, G Schaison, Guy Cornu	2
20	[Clinical and biological evaluation of the preventive role of anti-cytomegalovirus specific immunoglobulins in bone marrow grafts. Randomized study of 60 patients]. 1987 ·PubMed ·Pierre Bordigoni, C. Janot, (unknown), Francis Witz, (unknown), Bernard Legras, (unknown), D Olive, F Streiff	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact